I came across this vid on YouTube which I thought interesting. It is a news piece about cloned food. It is not an alarmist, conspiracy theorist piece, but a regular news brief. The reason I post it though, is that I think it is demonstrative of the way growing numbers of people are being informed. YouTube allows you to subscribe to specific topics as well as to specific producers of video. I subscribe for anything posted with a tag "FDA". As YouTube grows in popularity, it is going to become a greater and greater "news" venue. For pharma, a lack of involvement in this space now means a tremendous amount of work in catch-up later, making the move by Johnson & Johnson this week in creating their channel, even of greater import.
About the AuthorMy name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.
My ProfileI am an authority on regulatory aspects of communications and medical products, with particular emphasis on pre-approval communications; strategist to help pharma and biotech companies prepare best case for advisory committee approval; and counselor in issues and crisis management. I am a frequent speaker on various aspects of same - drug development, promotion, reimbursement and new media in a highly regulated environment. Author of books, newspaper and magazine pieces related to drug marketing and promotion as well as HIV specialty pieces. And of course... blogger!
About This BlogEye on FDA is published by Mark Senak of FleishmanHillard's Washington, D.C. office. The thoughts and ideas in this blog and postings are strictly my own and are not screened by my employer. Everything posted on this blog is my personal opinion and does not necessarily represent the views of FleishmanHillard or its clients.
Posts by Date